PIPA5112893

SSX2 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5112893-Each-of-1 In Stock ₹ 43,120.50

PIPA5112893 - Each of 1

₹ 43,120.50

In Stock

Quantity

1

Base Price: ₹ 43,120.50

GST (18%): ₹ 7,761.69

Total Price: ₹ 50,882.19

Antigen

SSX2

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Ssx2

Gene Alias

cancer/testis antigen 5.2; cancer/testis antigen family 5, member 2a; CT5.2; CT5.2A; CT52; HD21; HOM-MEL-40; LOC103690782; MGC119055; MGC15364; MGC3884; Protein SSX2; putative protein SSX10; sarcoma, synovial, X-chromosome-related 2; SSX; SSX family member 2; SSX2; SSX2A; SSX2B; Synovial sarcoma, X breakpoint 2; synovial sarcoma, X breakpoint 2B; tumor antigen HOM-MEL-40

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

6757

Content And Storage

-20°C or -80°C if preferred

Form

Liquid

Applications

ELISA, Immunohistochemistry (Paraffin), Western Blot

Concentration

0.32 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.3

Gene Accession No.

Q16385

Gene Symbols

Ssx2

Immunogen

Recombinant Human Protein SSX2 protein (1-188AA)

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5113101

--

Img

Thermo Scientific

PIPA5112601

--

Img

Thermo Scientific

PIPA5113135

--

Img

Thermo Scientific

PIPA5113124

--

Img

Thermo Scientific

PIPA5112408

--

Img

Thermo Scientific

PIPA5112912

--

Img

Thermo Scientific

PIPA5112920

--

Img

Thermo Scientific

PIPA5112921

--

Description

  • SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins
  • These proteins may function as transcriptional repressors
  • They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy
  • SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas
  • This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X
  • The encoded hybrid proteins are probably responsible for transforming activity
  • Two transcript variants encoding distinct isoforms have been identified for this gene.